Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
natural tags : Pre-clinical save search
Janssen Announces Novel Dengue Antiviral Demonstrates Efficacy in Pre-Clinical Data Published in Nature
Published: 2023-03-15 (Crawled : 17:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.7%
H: 1.34%
C: 0.99%
pre-clinical antiviral dengue
Gritstone Announces Results from Preclinical Study of its Self-amplifying mRNA (samRNA) Vaccine Against SARS-CoV-2 Published in Nature Communications
Published: 2022-06-10 (Crawled : 13:00) - biospace.com/
GRTS | $0.7414 -0.31% -0.31% 1.5M
|
Health Technology
|
| O: -2.6%
H: 0.0%
C: 0.0%
preclinical communications vaccine mrna sars-cov-2 results pre-clinical
Cellectis Publishes Two Articles in Nature Communications Providing Strong Preclinical Validation of UCART123 to Treat AML and BPDCN
Published: 2022-04-28 (Crawled : 19:00) - biospace.com/
CLLS | $2.47 0.4% 12K
|
Health Technology
|
| O: -1.31%
H: 0.53%
C: -3.7%
ucart123 preclinical aml communications pre-clinical
Repare Therapeutics Announces Publication of Preclinical Data in Nature Demonstrating the Potential of PKMYT1 Inhibitor RP-6306 in Tumors With CCNE1 Amplification
Published: 2022-04-20 (Crawled : 17:00) - biospace.com/
RPTX 4 | $3.14 3.97% 3.82% 220K
|
Health Technology
|
| O: 1.19%
H: 1.6%
C: 0.25%
rp-6306 preclinical therapeutics potential publication pre-clinical
Alpine Immune Sciences Publishes Key Preclinical Rationale for Davoceticept (ALPN-202), a First-in-Class CD28 Costimulator and Dual Checkpoint Inhibitor, in Nature Communications
Published: 2022-04-04 (Crawled : 13:20) - biospace.com/
ALPN | $64.535 0.16% 0.16% 4M
|
Health Technology
|
| O: 1.11%
H: 5.95%
C: 3.64%
alpn-202 preclinical communications pre-clinical
Oncolytics Biotech® Announces Publication of Preclinical and Patient Data Demonstrating Pelareorep's Stimulation of Natural Killer Cell Anti-Cancer Activity
Published: 2022-03-17 (Crawled : 19:00) - biospace.com/
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 3.95%
H: 5.7%
C: 2.53%
biotech cel preclinical cancer iot pre-clinical
Celularity Presents Preclinical Data on Allogeneic Genetically Modified Natural Killer (NK) and Allogeneic CAR-NK Cell Therapy Programs at the 63rd American Society of Hematology Meeting and Exposition
Published: 2021-12-13 (Crawled : 15:30) - biospace.com/
CELU | News F | $3.09 -3.74% -3.88% 24K
|
|
| O: -1.42%
H: 0.0%
C: 0.0%
ema genetic preclinical therapy pre-clinical
Celularity Presents Preclinical Data on Allogeneic Genetically-Modified Natural Killer Cells at the Society for Immunotherapy of Cancer 36th Annual Meeting
Published: 2021-11-15 (Crawled : 13:30) - globenewswire.com
CELU | News F | $3.09 -3.74% -3.88% 24K
|
|
| O: -1.8%
H: 0.0%
C: -4.22%
preclinical genetic immunotherapy therapy cancer pre-clinical
Innovent Publishes the Preclinical Results of IBI319 (Anti PD-1/CD137 Bispecific Antibody) in Nature Communications
Published: 2021-11-08 (Crawled : 01:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -1.59%
H: 0.0%
C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 1.38%
H: 0.98%
C: -2.62%
results communication antibody communications preclinical pre-clinical
Pre-clinical data on HOOKIPA’s arenaviral immunotherapeutic in melanoma published in Nature Communications
Published: 2021-08-05 (Crawled : 10:00) - globenewswire.com
HOOK | $0.7317 -4.34% -4.54% 420K
|
Health Technology
|
| O: 3.36%
H: 0.52%
C: 0.0%
pre-clinical communication communications preclinical
IGM Biosciences Announces Expansion of IgM Platform into Infectious Diseases, Publication of Preclinical Data in Nature Demonstrating Engineered IgM Antibody Antiviral Activity for the Treatment and Prevention of COVID-19
Published: 2021-06-03 (Crawled : 14:00) - igmbio.com
IGMS | $7.2 -2.83% -2.92% 220K
|
Health Technology
|
| O: 1.77%
H: 11.4%
C: 6.85%
covid disease treatment infectious disease expansion antiviral antibody preclinical pre-clinical
Affimed Announces Publication of Preclinical Data in Clinical Cancer Research Supporting Therapeutic Potential of AFM13 in Combination with Natural Killer Cells
Published: 2021-05-13 (Crawled : 21:00) - affimed.com
AFMD | $5.15 1.58% 1.55% 64K
|
Health Technology
|
| O: -0.56%
H: 6.24%
C: -0.11%
potential cancer research preclinical pre-clinical
Data from Codiak’s exoSTING™ Preclinical Development Program for the Treatment of Solid Tumors Published in the Nature Research Publication, Communications Biology
Published: 2021-04-22 (Crawled : 12:00) - biospace.com/
CDAK | $0.057 -55.99% -131.25% 0
|
Health Technology
|
| O: 3.33%
H: 35.26%
C: 30.31%
treatment solid tumors communication communications research preclinical pre-clinical
Study Published in Nature Shows F-Star’s STING Agonist SB 11285 Enhances Preclinical Efficacy of Radiation Therapy
Published: 2021-04-19 (Crawled : 14:00) - globenewswire.com
FSTX | $7.12 0.0% 0
|
Health Technology
|
| O: 7.79%
H: 0.46%
C: -11.25%
therapy radiation therapy preclinical pre-clinical
Pfizer and BioNTech Publish Preclinical Data from Investigational COVID-19 Vaccine Program in Nature
Published: 2021-02-01 (Crawled : 14:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.08%
H: 0.72%
C: -0.36%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 0.78%
H: 1.43%
C: -1.48%
covid vaccine preclinical covid-19 program pre-clinical
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.